Jessica Hagen

The AI brokerage company, which launched in January with $60 million in funding, announced its acquisition of Medicare brokerage agency Avid Health earlier this month.

Robert Capobianco, chief operating officer of NeuroFlow, discusses the rising demand for mental health services and the healthcare system's limited capacity to meet it.

Joyful Health secured $17 million for AI revenue cycle management offering, and Osteoboost Health closed an $8 million round for its wearable osteopenia device.

The CYBORG study will evaluate the company's muscle-machine interface, which uses an implantable sensor array in an amputee's residual limb to enable real-time, intuitive control of prosthetic limbs and robotic systems.

The retail giant's platform will now include obesity and weight management support from Wheel, Curai Health, Aaptiv, Berry Street and MyCare by Twin Health.

The partnership allows patients to purchase DEXA body composition scans, review results and receive a personalized care plan from a physician within Hone Health's app.

The company will use the funds to expand its commercial operations, grow its workforce, and scale its platform and infrastructure.

The platform offers AI models and agents that help scientists design, test and iterate experiments to identify and analyze potential antibody therapies.

The company's agentic platform works to help pharmaceutical companies turn data into automated analyses, strategic insights and commercialization tools.

The pharma giant will deploy OpenAI's most advanced capabilities across its global operations, from drug discovery to commercial functions, and upskill its workforce in AI literacy.